Rho Kinase: An Important Mediator of Atherosclerosis and Vascular Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|15|27|3108-3115

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.27, 2009-09, pp. : 3108-3115

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Atherosclerosis and Vascular Disease: Effects of Peptide Mimetics of Apolipoproteins

By  

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 4, 2006-08 ,pp. : 235-240

Bentham Science Publishers

Access to resources Recommend Favorite

Vitamin D in Atherosclerosis, Vascular Disease, and Endothelial Function

By  

Current Drug Targets, Vol. 12, Iss. 1, 2011-01 ,pp. : 54-60

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of Rosuvastatin versus Atorvastatin on Rho-associated Coiled-coil Containing Protein Kinase Activity and Endothelial Function in Patients with Atherosclerosis

By Liu B   Cao HM   Li GY   Liu M   Feng J   Li J   Wang Q  

The Journal of International Medical Research, Vol. 39, Iss. 6, 2011-11 ,pp. : 2314-2322

Field House Publishing

Access to resources Recommend Favorite

The role of NADPH Oxidase in Vascular Disease – Hypertension, Atherosclerosis

By  

Current Pharmaceutical Design, Vol. 21, Iss. 41, 2015-12 ,pp. : 5933-5944

Bentham Science Publishers

Access to resources Recommend Favorite

Involvement of Rho-kinase in vascular remodeling caused by long-term inhibition of nitric oxide synthesis in rats

By Ikegaki I.   Hattori T.   Yamaguchi T.   Sasaki Y.   Satoh S.-i.   Asano T.   Shimokawa H.  

European Journal of Pharmacology, Vol. 427, Iss. 1, 2001-09 ,pp. : 69-75

Elsevier

Access to resources Recommend Favorite